EBITDA

A near-record number of homeowners are delisting their properties in a silent retreat, signaling a major power shift from sellers to buyers.

With its massive Resulticks acquisition delayed again, London's Diginex tests investor faith, betting its future on an audacious ethics-meets-commerce vision.

As Prime Medicine prepares for a key investor conference, its next-gen 'search and replace' gene editing technology faces a crucial test. Can it deliver on its promise?

MetTel's recent Gartner recognition is more than an accolade; it's a signpost for the future of work where AI and automation manage our corporate devices.

The AI arms race for model size is over. In Silicon Valley, a new consensus emerges: efficiency, data quality, and real-world deployment are the new frontiers.

Consuelo Vanderbilt Costin's recurring role at the elite Forbes Iconoclast Summit is no social engagement. It's a masterclass in converting legacy into currency.

Liberty Waste Solutions' latest acquisition is more than a local deal; it's a look inside private equity's playbook for dominating essential services.

At a Vancouver gala, Neighbourhood Pharmacies didn't just give out awards; it signaled a strategic shift. Meet the leaders pushing pharmacies into a new era.

Amazon's historic rise to No. 1 on the Fortune 500 signals a definitive power shift, crowning the digital economy over traditional American business.

A new report shows California's self-insured employers face a puzzling trend: workers' comp claims are at a 5-year low, yet costs are surging. Why?

JohnsByrne's new sustainability report reveals impressive green metrics, but what does it mean for the luxury market? We explore how innovation is solving the premium paradox.

While others debate AI's future, CEO Eric Vaughan brings a radical playbook of M&A and cultural overhaul to the main stage, proving enterprise AI is here.

As The Conference Board honors S&P Global and UL Solutions, it’s clear that investing in people is no longer a soft skill—it's the core of modern strategy.

Stonegate Capital's updated coverage validates AB Science's pivot to ALS and AML, but can its promising clinical assets and shrewd financing de-risk the path forward?

A new platform, Risk Monitor, automates the tracking of permits, community sentiment, and environmental data to help developers stay ahead of project-killing risks.

Austin's ActivTrak sells software to monitor workplace productivity. As it wins another top workplace award, we ask: is it practicing what it preaches?

Kot Auto Group's latest acquisition isn't just about selling more cars. It's about building the centralized physical and service network for our automotive future.

With a recent return to profitability and a booming EV charging division, Orion Energy Systems heads to a Vegas investor conference. Is this a new chapter?

QuadReal's appointment of Deloitte veteran Trevor Nakka signals a strategic pivot, adding elite financial governance to its $98.5B portfolio to fuel a disciplined global expansion.

Upcoming study results for Bayer's KERENDIA could unlock a new treatment for millions with non-diabetic chronic kidney disease, a vast and underserved group.